"FDA has received a significant number of inquiries from members of the public and the health care community in response to this order to ECT manufacturers. In recognition of this significant public interest, FDA is opening this docket to permit individuals other than manufacturers to submit information related to the safety and effectiveness of ECT." <http://www.gpo.gov/fdsys/pkg/FR-2009-09-10/html/E9-21807.htm>http://www.gpo.gov/fdsys/pkg/FR-2009-09-10/html/E9-21807.htm or http://bit.ly/5mHC6 Make public comments here: <http://www.regulations.gov/search/Regs/home.html#submitComment?R=0900006480a20202>http://www.regulations.gov/search/Regs/home.html#submitComment?R=0900006480a20202 or http://bit.ly/Y2GSK Comment here about adverse affects: <https://www.accessdata.fda.gov/scripts/medwatch/medwatch-online.htm>https://www.accessdata.fda.gov/scripts/medwatch/medwatch-online.htm Comments to date: http://www.regulations.gov/search/Regs/home.html#docketDetail?R=FDA-2009-N-0392 I added some shorter links in case you'd like to send this information to your networks. Sylvia Powered by LSoft's LISTSERV(R) list management software